[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367791-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367791-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-distinct-mechanism-of-epigenetic-reprogramming-silences-pax2-and-initiates-endometrial-carcinogenesis","A distinct mechanism of epigenetic reprogramming silences PAX2 and initiates endometrial carcinogenesis","","Functional inactivation of tumor suppressor genes drives endometrial cancer initiation and progression. The study reports a distinct third mechanism, where histone alterations—not DNA sequence changes—recurrently inactivate PAX2 in over 80% of human endometrial cancers. Multi-omics, 3D genomic, and machine learning analyses link PAX2 downregulation to chromatin remodeling from active marks (H3K27ac/H3K4me3) to repressive H3K27me3 regulated by genome architecture, superenhancer loss, and cohesin-modulated spread. Preclinical mouse and human models show PAX2 loss promotes carcinogenesis through global enhancer reprogramming.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-distinct-mechanism-of-epigenetic-reprogramming-silences-pax2-and-initiates-endometrial-carcinogenesis/367791/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-distinct-mechanism-of-epigenetic-reprogramming-silences-pax2-and-initiates-endometrial-carcinogenesis/367791.png","ImageObject",300,407,{"name":42,"@type":43},"McGucket","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the distinct mechanism of tumor suppressor inactivation proposed in this study?","Question",{"text":63,"@type":64},"The study shows a third mechanism based on histone alterations rather than DNA code changes, leading to epigenetic silencing of the tumor suppressor PAX2.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is PAX2 inactivated in most human endometrial cancers?",{"text":68,"@type":64},"PAX2 is recurrently inactivated through an epigenetic reprogramming event associated with replacement of active chromatin features (H3K27ac/H3K4me3) by repressive H3K27me3 marks.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does chromatin architecture and cohesin play in PAX2 silencing?",{"text":72,"@type":64},"The spread of the repressive H3K27me3 signal is described as cohesin-loop modulated, preventing transcriptional dysregulation of neighboring genes while silencing PAX2.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367791,1790721130,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","The Journal of Clinical Investigation RESEAR CH ARTICLE  \nA distinct mechanism of epigenetic reprogramming silences PAX2 and initiates endometrial carcinogenesis  \nSubhransu S. Sahoo,1 Susmita G. Ramanand,1 Ileana C. Cuevas,2 Yunpeng Gao,1 Sora Lee,1 Ahmed Abbas,1 Xunzhi Zhang,3 Ashwani Kumar,3 Prasad Koduru,1,4 Sambit Roy,1 Russell R. Broaddus,5 Victoria L. Bae-Jump,6 Andrew B. Gladden,5 Jayanthi Lea,4,7,8 Elena Lucas,1,4 Chao Xing,3 Akio Kobayashi,9 Ram S. Mani,1,4,10 and Diego H. Castrillon1,4,8  \n1Department of Pathology, 2Department of Internal Medicine, 3McDermott Center of Human Growth and Development, and 4Harold C. Simmons Comprehensive Cancer Center, UT Southwestern, Dallas, Texas, USA. 5Department of Pathology and Lab Medicine, and 6Division of Gynecologic Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. 7Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, and 8Department of Obstetrics and Gynecology, UT Southwestern, Dallas, Texas, USA. 9Department of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan. 10Department of Urology, UT Southwestern, Dallas, Texas, USA.  \nFunctional inactivation of tumor suppressor genes drives cancer initiation, progression, and treatment responses. Most tumor suppressor genes are inactivated through 1 of 2 well-characterized mechanisms: DNA-level mutations, such as point mutations or deletions, and promoter DNA hypermethylation. Here, we report a distinct third mechanism of tumor suppressor inactivation based on alterations to the histone rather than DNA code. We demonstrated that PAX2 is an endometrial tumor suppressor recurrently inactivated by a distinct epigenetic reprogramming event in more than 80% of human endometrial cancers. Integrative transcriptomic, epigenomic, 3D genomic, and machine learning analyses showed that PAX2 transcriptional downregulation is associated with replacement of open/active chromatin features (H3K27ac/H3K4me3) with inaccessible/repressive chromatin features (H3K27me3) in a framework dictated by 3D genome organization. The spread of the repressive H3K27me3 signal resembled a pearl necklace, with its length modulated by cohesin loops, thereby preventing transcriptional dysregulation of neighboring genes. This mechanism, involving the loss of a promoter-proximal superenhancer, was shown to underlie transcriptional silencing of PAX2 in human endometrial cancers. Mouse and human preclinical models established PAX2 as a potent endometrial tumor suppressor. Functionally, PAX2 loss promoted endometrial carcinogenesis by rewiring the transcriptional landscape via global enhancer reprogramming. The discovery that most endometrial cancers originate from a recurring epigenetic alteration carries profound implications for their diagnosis and treatment.  \nIntroduction  \nEndometrial cancer (EC) accounts for 7% of all cancers and is the fourth most common cancer in women, with more than 68,000 cases anticipated per year in the United States. In 2024, for the first time, EC deaths exceeded those of ovarian cancer (13,250 vs. 12,750) (1), underscoring EC’s significance as a women’s health issue. In contrast to declining incidence and improved survival formost cancers, EC incidence and mortality have been increasing over the past 40 years, by approximately 1% each year (1, 2) . Age is the most significant risk factor, with EC incidence peaking in the seventh decade. Increasing life expectancy and other risk factors such as obesity contribute to EC’s rising incidence, but other poorly understood environmental and genetic factors are also at play (3–5) .  \nEC arises from epithelial cells through a preinvasive histologic precursor termed endometrioid intraepithelial neoplasia (EIN), which progresses to invasive and lethal endometrioid adenocar-  \nConflict of interest: The authors have declared that no conflict of interest exists. Copyright: © 2025, Sahoo et","cbCaiarZKVGDMyWD","https://ap.wps.com/l/cbCaiarZKVGDMyWD","pdf",23524642,17,"English","# Introduction\n## Tumor suppressor inactivation mechanisms\n## Endometrial cancer background and risk factors\n## PAX2 biology and relevance to endometrial disease","[{\"question\":\"What is the distinct mechanism of tumor suppressor inactivation proposed in this study?\",\"answer\":\"The study shows a third mechanism based on histone alterations rather than DNA code changes, leading to epigenetic silencing of the tumor suppressor PAX2.\"},{\"question\":\"How is PAX2 inactivated in most human endometrial cancers?\",\"answer\":\"PAX2 is recurrently inactivated through an epigenetic reprogramming event associated with replacement of active chromatin features (H3K27ac/H3K4me3) by repressive H3K27me3 marks.\"},{\"question\":\"What role does chromatin architecture and cohesin play in PAX2 silencing?\",\"answer\":\"The spread of the repressive H3K27me3 signal is described as cohesin-loop modulated, preventing transcriptional dysregulation of neighboring genes while silencing PAX2.\"}]","A distinct mechanism of epigenetic reprogramming silences PAX2 and initiates endometrial carcinogenesis | PDF",1790172668,43,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14e9b11245729db81011a0fc5b08ad24.webp",983,1315,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e3199259eaa539f873f1d61e1b3e4cf.webp",982,1314,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e085bc6e529e641d5922ebca65c04f1.webp",981,1312,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3f7d100ba44351541764489f86e0acb.webp",980,1311]